Experimental mRNA therapy dramatically extends treatment window for acetaminophen overdose in preclinical models
When a patient arrives at the hospital with an acetaminophen overdose, it's often a race against the clock. The only FDA-approved antidote for overdose-related liver injury, N‑acetylcysteine, must be administered within hours to be effective.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Resistance gene helps C. difficile spores survive hospital-grade disinfectants
United Kingdom
-
Blueberries can modify the gut microbiome in older adults with mild depression
United Kingdom
-
Exercise as medicine—how exercise protects joints in aging-related osteoarthritis
United Kingdom
-
Early complications common in older kidney transplant recipients
United Kingdom
-
Tiny blood clots help guide blood flow as placenta develops, mouse study finds
United Kingdom
-
1997 to 2022 saw an increase in pediatric hospitalizations with acute kidney injury
United Kingdom
-
Emergency room intervention pairs smartphone and telehealth counseling to reduce risky firearm behavior
United Kingdom
-
Microplastics clog liver immune cells, driving fat buildup in mice
United Kingdom